Varicella-zoster virus reactivation after SARS-CoV-2 BNT162b2 mRNA vaccination: Report of 5 cases
JAAD Case Rep
.
2021 Jun;12:58-59.
doi: 10.1016/j.jdcr.2021.04.014.
Epub 2021 Apr 24.
Authors
Pedro Rodríguez-Jiménez
1
,
Pablo Chicharro
1
,
Luisa-Martos Cabrera
1
,
Mireia Seguí
1
,
Álvaro Morales-Caballero
2
,
Mar Llamas-Velasco
1
,
Javier Sánchez-Pérez
2
Affiliations
1
Department of Dermatology, Instituto de Investigación Sanitaria la Princesa (IIS-IP), Hospital Universitario de La Princesa, Madrid, Spain.
2
Department of Preventive Medicine, Hospital Universitario de La Princesa, Madrid, Spain.
PMID:
33937467
PMCID:
PMC8071473
DOI:
10.1016/j.jdcr.2021.04.014
No abstract available
Keywords:
COVID-19; VZV, varicella-zoster virus; herpes virus; herpes zoster; pandemic.
Publication types
Case Reports